Avita Medical Financials
RCEL Stock | USD 13.00 0.18 1.40% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Debt Equity Ratio | 0.0103 | 0.0077 |
|
| |||||
Current Ratio | 12.54 | 9.41 |
|
|
The essential information of the day-to-day investment outlook for Avita Medical includes many different criteria found on its balance sheet. An individual investor should monitor Avita Medical's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Avita Medical.
Net Income |
|
Avita | Select Account or Indicator |
Avita Medical Earnings Geography
Avita Medical Stock Summary
Avita Medical competes with Clearpoint Neuro, Sight Sciences, Treace Medical, Rxsight, and Axogen. AVITA Medical, Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. AVITA Medical, Inc. was incorporated in 2000 and is based in Valencia, California. Avita Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 116 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US05380C1027 |
CUSIP | 05380C102 053792107 |
Location | California; U.S.A |
Business Address | 28159 Avenue Stanford, |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.avitamedical.com |
Phone | 661 367 9170 |
Currency | USD - US Dollar |
Avita Medical Key Financial Ratios
Return On Equity | -1.52 | ||||
Profit Margin | (0.95) % | ||||
Operating Margin | (0.71) % | ||||
Price To Sales | 5.61 X | ||||
Revenue | 50.14 M |
Avita Medical Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Other Current Liab | 455.5K | (1.4M) | (957K) | 6.9M | 338K | 321.1K | |
Retained Earnings | (128.7M) | (282.4M) | (194.9M) | (385.7M) | (298.0M) | (283.1M) | |
Net Receivables | 2.1M | 3.5M | 2.4M | 5.2M | 7.7M | 8.0M | |
Total Current Assets | 24.2M | 113.6M | 78.4M | 128.5M | 104.0M | 109.2M | |
Inventory | 740.8K | 1.6M | 1.1M | 3.1M | 5.6M | 5.9M | |
Other Current Assets | 1.1M | 1.7M | 990K | 3.6M | 4.2M | 4.4M | |
Accounts Payable | 3.9M | 6.3M | 4.3M | 4.4M | 3.8M | 4.0M | |
Other Liab | 471K | 435K | 1.6M | 2.5M | 2.9M | 3.0M | |
Net Tangible Assets | 20.6M | 72.0M | 115.2M | 84.3M | 96.9M | 51.6M |
Avita Medical Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | (19.2M) | 78.0M | 53.5M | (121.3M) | 4.0M | 4.2M | |
Capital Expenditures | 1.3M | 854.9K | 847K | 663.9K | 1.4M | 1.5M | |
Net Income | (24.6M) | (60.9M) | (42.0M) | (39.2M) | (35.4M) | (33.6M) | |
End Period Cash Flow | (19.2M) | 107.0M | 73.8M | 26.7M | 22.1M | 13.5M | |
Depreciation | 264.7K | 673.8K | 465K | 834.3K | 632K | 448.0K | |
Change To Inventory | 68.7K | (678.1K) | (468K) | (545.0K) | (3.7M) | (3.5M) | |
Investments | (1.3M) | (847K) | (1.2M) | (19.3M) | 1.6M | 1.7M | |
Change To Netincome | 2.3M | 17.5M | 6.9M | 7.9M | 9.0M | 5.5M |
Avita Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Avita Medical's current stock value. Our valuation model uses many indicators to compare Avita Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Avita Medical competition to find correlations between indicators driving Avita Medical's intrinsic value. More Info.Avita Medical is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Avita Medical's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Avita Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Avita Medical Systematic Risk
Avita Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Avita Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-eight with a total number of output elements of thirty-three. The Beta measures systematic risk based on how returns on Avita Medical correlated with the market. If Beta is less than 0 Avita Medical generally moves in the opposite direction as compared to the market. If Avita Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Avita Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Avita Medical is generally in the same direction as the market. If Beta > 1 Avita Medical moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Avita Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Avita Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Avita Medical growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Avita Medical December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Avita Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Avita Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Avita Medical based on widely used predictive technical indicators. In general, we focus on analyzing Avita Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Avita Medical's daily price indicators and compare them against related drivers.
Downside Deviation | 2.77 | |||
Information Ratio | 0.1456 | |||
Maximum Drawdown | 13.45 | |||
Value At Risk | (3.33) | |||
Potential Upside | 4.89 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avita Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avita Medical. If investors know Avita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avita Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.23) | Revenue Per Share 2.335 | Quarterly Revenue Growth 0.432 | Return On Assets (0.45) | Return On Equity (1.52) |
The market value of Avita Medical is measured differently than its book value, which is the value of Avita that is recorded on the company's balance sheet. Investors also form their own opinion of Avita Medical's value that differs from its market value or its book value, called intrinsic value, which is Avita Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avita Medical's market value can be influenced by many factors that don't directly affect Avita Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avita Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avita Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avita Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.